146 related articles for article (PubMed ID: 9972858)
1. The type IV phosphodiesterase inhibitors, Ro 20-1724 and rolipram, block the initiation of cocaine self-administration.
Knapp CM; Foye MM; Ciraulo DA; Kornetsky C
Pharmacol Biochem Behav; 1999 Jan; 62(1):151-8. PubMed ID: 9972858
[TBL] [Abstract][Full Text] [Related]
2. Cyclic AMP-specific phosphodiesterase inhibitor rolipram and RO-20-1724 promoted apoptosis in HL60 promyelocytic leukemic cells via cyclic AMP-independent mechanism.
Zhu WH; Majluf-Cruz A; Omburo GA
Life Sci; 1998; 63(4):265-74. PubMed ID: 9698035
[TBL] [Abstract][Full Text] [Related]
3. Additive effects of intra-accumbens infusion of the cAMP-specific phosphodiesterase inhibitor, rolipram and cocaine on brain stimulation reward.
Knapp CM; Lee K; Foye M; Ciraulo DA; Kornetsky C
Life Sci; 2001 Aug; 69(14):1673-82. PubMed ID: 11589507
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of pig aortic smooth muscle cell DNA synthesis by selective type III and type IV cyclic AMP phosphodiesterase inhibitors.
Souness JE; Hassall GA; Parrott DP
Biochem Pharmacol; 1992 Sep; 44(5):857-66. PubMed ID: 1326964
[TBL] [Abstract][Full Text] [Related]
5. The Type IV phosphodiesterase inhibitor rolipram interferes with drug-induced conditioned place preference but not immediate early gene induction in mice.
Thompson BE; Sachs BD; Kantak KM; Cherry JA
Eur J Neurosci; 2004 May; 19(9):2561-8. PubMed ID: 15128409
[TBL] [Abstract][Full Text] [Related]
6. Involvement of rolipram-sensitive cyclic AMP phosphodiesterase in the regulation of cardiac contraction.
Muller B; Lugnier C; Stoclet JC
J Cardiovasc Pharmacol; 1990 Nov; 16(5):796-803. PubMed ID: 1703603
[TBL] [Abstract][Full Text] [Related]
7. Characteristic behavioural alterations in rats induced by rolipram and other selective adenosine cyclic 3', 5'-monophosphate phosphodiesterase inhibitors.
Wachtel H
Psychopharmacology (Berl); 1982; 77(4):309-16. PubMed ID: 6182575
[TBL] [Abstract][Full Text] [Related]
8. Behavioral effects of family-selective inhibitors of cyclic nucleotide phosphodiesterases.
O'Donnell JM; Frith S
Pharmacol Biochem Behav; 1999 May; 63(1):185-92. PubMed ID: 10340540
[TBL] [Abstract][Full Text] [Related]
9. Rat homologs of the Drosophila dunce gene code for cyclic AMP phosphodiesterases sensitive to rolipram and RO 20-1724.
Henkel-Tigges J; Davis RL
Mol Pharmacol; 1990 Jan; 37(1):7-10. PubMed ID: 2153912
[TBL] [Abstract][Full Text] [Related]
10. Potential antidepressant activity of rolipram and other selective cyclic adenosine 3',5'-monophosphate phosphodiesterase inhibitors.
Wachtel H
Neuropharmacology; 1983 Mar; 22(3):267-72. PubMed ID: 6302550
[TBL] [Abstract][Full Text] [Related]
11. Characterization of cyclic AMP phosphodiesterase isozymes in rat parotid gland.
Imai A; Nashida T; Shimomura H
Arch Oral Biol; 1995 Feb; 40(2):165-8. PubMed ID: 7794130
[TBL] [Abstract][Full Text] [Related]
12. Administration of a cAMP phosphodiesterase 4 inhibitor enhances antidepressant-induction of BDNF mRNA in rat hippocampus.
Fujimaki K; Morinobu S; Duman RS
Neuropsychopharmacology; 2000 Jan; 22(1):42-51. PubMed ID: 10633490
[TBL] [Abstract][Full Text] [Related]
13. Imaging of cAMP-specific phosphodiesterase-IV: comparison of [11C]rolipram and [11C]Ro 20-1724 in rats.
Lourenco CM; DaSilva JN; Warsh JJ; Wilson AA; Houle S
Synapse; 1999 Jan; 31(1):41-50. PubMed ID: 10025682
[TBL] [Abstract][Full Text] [Related]
14. Antidepressant-like effects of rolipram and other inhibitors of cyclic adenosine monophosphate phosphodiesterase on behavior maintained by differential reinforcement of low response rate.
O'Donnell JM
J Pharmacol Exp Ther; 1993 Mar; 264(3):1168-78. PubMed ID: 8383740
[TBL] [Abstract][Full Text] [Related]
15. Differential inhibition of human neutrophil functions. Role of cyclic AMP-specific, cyclic GMP-insensitive phosphodiesterase.
Wright CD; Kuipers PJ; Kobylarz-Singer D; Devall LJ; Klinkefus BA; Weishaar RE
Biochem Pharmacol; 1990 Aug; 40(4):699-707. PubMed ID: 1696820
[TBL] [Abstract][Full Text] [Related]
16. Species differences in behavioural effects of rolipram and other adenosine cyclic 3H, 5H-monophosphate phosphodiesterase inhibitors.
Wachtel H
J Neural Transm; 1983; 56(2-3):139-52. PubMed ID: 6190991
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of chemotactic peptide-induced neutrophil adhesion to vascular endothelium by cAMP modulators.
Derian CK; Santulli RJ; Rao PE; Solomon HF; Barrett JA
J Immunol; 1995 Jan; 154(1):308-17. PubMed ID: 7995950
[TBL] [Abstract][Full Text] [Related]
18. Rolipram, a selective inhibitor of phosphodiesterase type 4, pronouncedly enhanced the forskolin-induced promotion of dopamine biosynthesis in primary cultured rat mesencephalic neurons.
Yamashita N; Miyashiro M; Baba J; Sawa A
Jpn J Pharmacol; 1997 Sep; 75(1):91-5. PubMed ID: 9334890
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of rolipram on partially purified phosphodiesterase 4 from rat brains.
Ohsawa F; Yamauchi M; Nagaso H; Murakami S; Baba J; Sawa A
Jpn J Pharmacol; 1998 Jun; 77(2):147-54. PubMed ID: 9681571
[TBL] [Abstract][Full Text] [Related]
20. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
Marcoz P; Prigent AF; Lagarde M; Nemoz G
Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
